Allergy Therapeutics (HHU) Financial Statements
Allergy Therapeutics Financial Overview
Allergy Therapeutics's market cap is currently $302.84M. The company's EPS TTM is $-0.01; its P/E ratio is -4.04; Allergy Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 55.04M | $ 55.20M | $ 59.59M | $ 72.77M | $ 84.33M |
| Gross Profit | $ 25.13M | $ 29.74M | $ 32.69M | $ 48.95M | $ 61.80M |
| Operating Income | $ -29.50M | $ -35.26M | $ -34.85M | $ -13.00M | $ 4.03M |
| EBITDA | $ -29.43M | $ -30.74M | $ -36.24M | $ -8.69M | $ 7.61M |
| Net Income | $ -40.13M | $ -40.22M | $ -43.07M | $ -13.78M | $ 2.89M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 12.79M | $ 12.91M | $ 14.85M | $ 20.52M | $ 40.27M |
| Total Assets | $ 67.54M | $ 64.83M | $ 66.77M | $ 72.95M | $ 88.09M |
| Total Debt | $ 60.09M | $ 30.99M | $ 35.99M | $ 10.53M | $ 11.17M |
| Net Debt | $ 47.50M | $ 18.07M | $ 21.14M | $ -9.99M | $ -29.10M |
| Total Liabilities | $ 95.74M | $ 61.12M | $ 64.70M | $ 35.18M | $ 39.55M |
| Stockholders' Equity | $ -28.19M | $ 3.71M | $ 2.07M | $ 37.77M | $ 48.53M |
| Cash Flow | |||||
| Free Cash Flow | $ -31.98M | $ -35.54M | $ -35.59M | $ -17.17M | $ 5.95M |
| Operating Cash Flow | $ -28.72M | $ -32.14M | $ -30.92M | $ -14.11M | $ 8.52M |
| Investing Cash Flow | $ -3.15M | $ -1.20M | $ -4.67M | $ -3.06M | $ -2.76M |
| Financing Cash Flow | $ 32.04M | $ 31.43M | $ 29.91M | $ -2.64M | $ -2.03M |
Currency in GBP